• 75120 Citations
  • 134 h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jorge Eduardo Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

THERAPY OF CML

Cortes, J. E., Kurzrock, R., Ming-Sheng, L., Reading, C., Emerson, S., Liang, J., Deisseroth, A., Feinberg, A., Siciliano, M., Kantarjian, H., Talpaz, M., Andreeff, M., Kornblau, S., Thall, P., Issa, J. P., Estrov, Z., Arlinghaus, R. B., Deininger, M., Champlin, R., Shpall, E., Austin, D., Claxton, D., Belmont, J., Reisner, Y. & Issa, K.

National Institutes of Health

Project: Research project

  • Research Output

    Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia

    Kolitz, J. E., Strickland, S. A., Cortes, J. E., Hogge, D., Lancet, J. E., Goldberg, S. L., Villa, K. F., Ryan, R. J., Chiarella, M., Louie, A. C., Ritchie, E. K. & Stuart, R. K., Feb 23 2020, In : Leukemia and Lymphoma. 61, 3, p. 631-640 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia

    Sasaki, K., Kanagal-Shamanna, R., Montalban-Bravo, G., Assi, R., Jabbour, E., Ravandi, F., Kadia, T., Pierce, S., Takahashi, K., Nogueras Gonzalez, G., Patel, K., Soltysiak, K. A., Cortes, J., Kantarjian, H. M. & Garcia-Manero, G., Feb 15 2020, In : Cancer. 126, 4, p. 765-774 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia

    Naqvi, K., Jabbour, E., Skinner, J., Anderson, K., Dellasala, S., Yilmaz, M., Ferrajoli, A., Bose, P., Thompson, P., Alvarado, Y., Jain, N., Takahashi, K., Burger, J., Estrov, Z., Borthakur, G., Pemmaraju, N., Paul, S., Cortes, J. & Kantarjian, H. M., Jan 1 2020, In : Cancer. 126, 1, p. 67-75 9 p.

    Research output: Contribution to journalArticle

  • Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia

    Masarova, L., Cortes, J. E., Patel, K. P., O’Brien, S., Nogueras-Gonzalez, G. M., Konopleva, M., Verstovsek, S., Garcia-Manero, G., Ferrajoli, A., Kadia, T. M., Ravandi-Kashani, F., Borthakur, G., DellaSala, S., Estrov, Z., Jabbour, E. J. & Kantarjian, H. M., Jan 1 2020, (Accepted/In press) In : Cancer. 126, 7, p. 1448-1459 12 p.

    Research output: Contribution to journalArticle

  • Long-term results of frontline dasatinib in chronic myeloid leukemia

    Maiti, A., Cortes, J. E., Patel, K. P., Masarova, L., Borthakur, G., Ravandi, F., Verstovsek, S., Ferrajoli, A., Estrov, Z., Garcia-Manero, G., Kadia, T. M., Nogueras-González, G. M., Skinner, J., Poku, R., DellaSala, S., Luthra, R., Jabbour, E. J., O’Brien, S. & Kantarjian, H. M., Jan 1 2020, (Accepted/In press) In : Cancer. 126, 7, p. 1502-1511 10 p.

    Research output: Contribution to journalArticle